Vitamin D in liver diseases: From mechanisms to clinical trials

Journal of Gastroenterology and Hepatology (Australia)

Volumn 28, Issue SUPPL 1, 2013, Pages 49-55

  Han, Yuan Ping ^a,b   Kong, Ming ^b   Zheng, Sujun ^b   Ren, Yan ^b   Zhu, Longdon ^b   Shi, Hongbo ^b   Duan, Zhongping ^b  

^a SICHUAN UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Alcoholic liver diseases (ALD); Cirrhosis; Fatty liver; Fibrosis; Hepaticsteatosis; Liver diseases; Vitamin D; Vitamin D deficiency.

Indexed keywords

BETA DEFENSIN; CALCITRIOL; CATHELICIDIN; CHOLESTANETRIOL 26 MONOOXYGENASE; CHOLESTEROL 7ALPHA MONOOXYGENASE; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 15; INTERFERON; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 5; RIBAVIRIN; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; VITAMIN D;

ALCOHOL LIVER DISEASE; ANTIGEN PRESENTING CELL; CALCIUM ABSORPTION; CALCIUM HOMEOSTASIS; CHRONIC LIVER DISEASE; CLINICAL TRIAL (TOPIC); DRUG EFFICACY; HEPATITIS C VIRUS; HUMAN; HYDROXYLATION; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; INNATE IMMUNITY; LIVER CIRRHOSIS; LIVER DISEASE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL; VIRUS HEPATITIS; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 84880437678     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12016     Document Type: Review

References (70)

1. Prosser DE, Jones G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem. Sci. 2004; 29: 664-673.
2. Chen KS, Prahl JM, DeLuca HF. Isolation and expression of human 1, 25-dihydroxyvitamin D3 24-hydroxylase cDNA. Proc. Natl Acad. Sci. U.S.A. 1993; 90: 4543-4547.
3. Adams JS, Sharma OP, Gacad MA, Singer FR. Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. J. Clin. Invest. 1983; 72: 1856-1860.
4. Reichel H, Koeffler HP, Bishop JE, Norman AW. 25-Hydroxyvitamin D3 metabolism by lipopolysaccharide-stimulated normal human macrophages. J. Clin. Endocrinol. Metab. 1987; 64: 1-9.
5. Reichel H, Bishop JE, Koeffler HP, Norman AW. Evidence for 1, 25-dihydroxyvitamin D3 production by cultured porcine alveolar macrophages. Mol. Cell. Endocrinol. 1991; 75: 163-167.
6. Overbergh L, Stoffels K, Waer M, Verstuyf A, Bouillon R, Mathieu C. Immune regulation of 25-hydroxyvitamin D-1alpha-hydroxylase in human monocytic THP1 cells: mechanisms of interferon-gamma-mediated induction. J. Clin. Endocrinol. Metab. 2006; 91: 3566-3574.
7. Germain P, Staels B, Dacquet C, Spedding M, Laudet V. Overview of nomenclature of nuclear receptors. Pharmacol. Rev. 2006; 58: 685-704.
8. Freedman LP. Transcriptional targets of the vitamin D3 receptor-mediating cell cycle arrest and differentiation. J. Nutr. 1999; 129: 581S-586.
9. Sulimovici S, Roginsky MS, Pfeifer RF. 25-Hydroxylation of vitamin D3 in liver microsomes and their smooth and rough subfractions. Methods Enzymol. 1980; 67: 441-444.
10. Inouye K, Sakaki T. Enzymatic studies on the key enzymes of vitamin D metabolism; 1 alpha-hydroxylase (CYP27B1) and 24-hydroxylase (CYP24). Biotechnol. Annu. Rev. 2001; 7: 179-194.
11. Norman AW, Roth J, Orci L. The vitamin D endocrine system: steroid metabolism, hormone receptors, and biological response (calcium binding proteins). Endocr. Rev. 1982; 3: 331-366.
12. Bouillon R, Van Cromphaut S, Carmeliet G. Intestinal calcium absorption: molecular vitamin D mediated mechanisms. J. Cell. Biochem. 2003; 88: 332-339.
13. Wang TT, Nestel FP, Bourdeau V etal. Cutting edge: 1, 25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol. 2004; 173: 2909-2912.
14. Hodler B, Evequoz V, Trechsel U, Fleisch H, Stadler B. Influence of vitamin D3 metabolites on the production of interleukins 1, 2 and 3. Immunobiology 1985; 170: 256-269.
15. Majewski S, Skopinska M, Marczak M, Szmurlo A, Bollag W, Jablonska S. Vitamin D3 is a potent inhibitor of tumor cell-induced angiogenesis. J. Investig. Dermatol. Symp. Proc. 1996; 1: 97-101.
16. Kankova M, Luini W, Pedrazzoni M etal. Impairment of cytokine production in mice fed a vitamin D3-deficient diet. Immunology 1991; 73: 466-471.
17. Fukumoto S. Actions and mode of actions of FGF19 subfamily members. Endocr. J. 2008; 55: 23-31.
18. Bhatnagar S, Damron HA, Hillgartner FB. Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis. J. Biol. Chem. 2009; 284: 10023-10033.
19. Nemere I, Zhou LX, Norman AW. Nontranscriptional effects of steroid hormones. Receptor 1993; 3: 277-291.
20. Morelli S, de Boland AR, Boland RL. Generation of inositol phosphates, diacylglycerol and calcium fluxes in myoblasts treated with 1, 25-dihydroxyvitamin D3. Biochem. J. 1993; 289 (Pt 3): 675-679.
21. Farach-Carson MC, Ridall AL. Dual 1, 25-dihydroxyvitamin D3 signal response pathways in osteoblasts: cross-talk between genomic and membrane-initiated pathways. Am. J. Kidney Dis. 1998; 31: 729-742.
22. Rodman JS, Baker T. Changes in the kinetics of muscle contraction in vitamin D-depleted rats. Kidney Int. 1978; 13: 189-193.
23. Bookout AL, Jeong Y, Downes M, Yu RT, Evans RM, Mangelsdorf DJ. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 2006; 126: 789-799.
24. Schmidt DR, Holmstrom SR, Fon Tacer K, Bookout AL, Kliewer SA, Mangelsdorf DJ. Regulation of bile acid synthesis by fat-soluble vitamins A and D. J. Biol. Chem. 2010; 285: 14486-14494.
25. Koeffler HP, Reichel H, Bishop JE, Norman AW. Gamma-Interferon stimulates production of 1, 25-dihydroxyvitamin D3 by normal human macrophages. Biochem. Biophys. Res. Commun. 1985; 127: 596-603.
26. Almerighi C, Sinistro A, Cavazza A, Ciaprini C, Rocchi G, Bergamini A. 1Alpha, 25-dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in human monocytes. Cytokine 2009; 45: 190-197.
27. Froicu M, Cantorna MT. Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol. 2007; 8: 1-13.
28. Kreutz M, Andreesen R, Krause SW, Szabo A, Ritz E, Reichel H. 1, 25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. Blood 1993; 82: 1300-1307.
29. Brennan A, Katz DR, Nunn JD etal. Dendritic cells from human tissues express receptors for the immunoregulatory vitamin D3 metabolite, dihydroxycholecalciferol. Immunology 1987; 61: 457-461.
30. Piemonti L, Monti P, Sironi M etal. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J. Immunol. 2000; 164: 4443-4451.
31. Gombart AF, Borregaard N, Koeffler HP. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1, 25-dihydroxyvitamin D3. FASEB J. 2005; 19: 1067-1077.
32. Liu PT, Stenger S, Li H etal. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311: 1770-1773.
33. Liu PT, Schenk M, Walker VP etal. Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS One 2009; 4: e5810.
34. Rigby WF, Stacy T, Fanger MW. Inhibition of T lymphocyte mitogenesis by 1, 25-dihydroxyvitamin D3 (calcitriol). J. Clin. Invest. 1984; 74: 1451-1455.
35. Lemire JM, Archer DC, Beck L, Spiegelberg HL. Immunosuppressive actions of 1, 25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. J. Nutr. 1995; 125: 1704S-1708.
36. Lemire JM, Adams JS, Sakai R, Jordan SC. 1 alpha, 25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J. Clin. Invest. 1984; 74: 657-661.
37. Morales-Tirado V, Wichlan DG, Leimig TE, Street SE, Kasow KA, Riberdy JM. 1alpha, 25-dihydroxyvitamin D3 (vitamin D3) catalyzes suppressive activity on human natural regulatory T cells, uniquely modulates cell cycle progression, and augments FOXP3. Clin. Immunol. 2011; 138: 212-221.
38. Smolders J, Damoiseaux J, Menheere P, Hupperts R. Vitamin D as an immune modulator in multiple sclerosis, a review. J. Neuroimmunol. 2008; 194: 7-17.
39. Smolders J, Thewissen M, Peelen E etal. Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS One 2009; 4: e6635.
40. Ghoreishi M, Bach P, Obst J, Komba M, Fleet JC, Dutz JP. Expansion of antigen-specific regulatory T cells with the topical vitamin D analog calcipotriol. J. Immunol. 2009; 182: 6071-6078.
41. Prietl B, Pilz S, Wolf M etal. Vitamin D supplementation and regulatory T cells in apparently healthy subjects: vitamin D treatment for autoimmune diseases? Isr. Med. Assoc. J. 2010; 12: 136-139.
42. Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O'Garra A. 1alpha, 25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J. Immunol. 2001; 167: 4974-4980.
43. Wittke A, Weaver V, Mahon BD, August A, Cantorna MT. Vitamin D receptor-deficient mice fail to develop experimental allergic asthma. J. Immunol. 2004; 173: 3432-3436.
44. Gorman S, Judge MA, Burchell JT, Turner DJ, Hart PH. 1, 25-dihydroxyvitamin D3 enhances the ability of transferred CD4+ CD25+ cells to modulate T helper type 2-driven asthmatic responses. Immunology 2010; 130: 181-192.
45. Taher YA, van Esch BC, Hofman GA, Henricks PA, van Oosterhout AJ. 1alpha, 25-dihydroxyvitamin D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: role for IL-10 and TGF-beta. J. Immunol. 2008; 180: 5211-5221.
46. Kitson MT, Roberts SK. D-livering the message: the importance of vitamin D status in chronic liver disease. J. Hepatol. 2012; 57: 897-909.
47. Abramovitch S, Dahan-Bachar L, Sharvit E etal. Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats. Gut 2011; 60: 1728-1737.
48. Holick MF, Binkley NC, Bischoff-Ferrari HA etal. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 2011; 96: 1911-1930.
49. Alavian SM, Mohammad-Alizadeh AH, Esna-Ashari F, Ardalan G, Hajarizadeh B. Non-alcoholic fatty liver disease prevalence among school-aged children and adolescents in Iran and its association with biochemical and anthropometric measures. Liver Int. 2009; 29: 159-163.
50. Alemzadeh R, Kichler J, Babar G, Calhoun M. Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season. Metabolism 2008; 57: 183-191.
51. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am. J. Clin. Nutr. 2004; 79: 820-825.
52. Smotkin-Tangorra M, Purushothaman R, Gupta A, Nejati G, Anhalt H, Ten S. Prevalence of vitamin D insufficiency in obese children and adolescents. J. Pediatr. Endocrinol. Metab. 2007; 20: 817-823.
53. Lenders CM, Feldman HA, Von Scheven E etal. Relation of body fat indexes to vitamin D status and deficiency among obese adolescents. Am. J. Clin. Nutr. 2009; 90: 459-467.
54. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 2005; 115: 1343-1351.
55. Fuchs M. Non-alcoholic Fatty liver disease: the bile Acid-activated farnesoid x receptor as an emerging treatment target. J Lipids. 2012; 2012: 934396.
56. Chen X, Chen F, Liu S etal. Transactivation of rat apical sodium-dependent bile acid transporter and increased bile acid transport by 1alpha, 25-dihydroxyvitamin D3 via the vitamin D receptor. Mol. Pharmacol. 2006; 69: 1913-1923.
57. Thummel KE, Brimer C, Yasuda K etal. Transcriptional control of intestinal cytochrome P-4503A by 1alpha, 25-dihydroxy vitamin D3. Mol. Pharmacol. 2001; 60: 1399-1406.
58. Drocourt L, Ourlin JC, Pascussi JM, Maurel P, Vilarem MJ. Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes. J. Biol. Chem. 2002; 277: 25125-25132.
59. Malham M, Jorgensen SP, Ott P etal. Vitamin D deficiency in cirrhosis relates to liver dysfunction rather than aetiology. World J. Gastroenterol. 2011; 17: 922-925.
60. Rahman AH, Branch AD. Vitamin D for your patients with chronic hepatitis C? J. Hepatol. 2013; 58: 184-189.
61. Petta S, Camma C, Scazzone C etal. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology 2010; 51: 1158-1167.
62. Abu-Mouch S, Fireman Z, Jarchovsky J, Zeina AR, Assy N. Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naive patients. World J. Gastroenterol. 2011; 17: 5184-5190.
63. Nimer A, Mouch A. Vitamin D improves viral response in hepatitis C genotype 2-3 naive patients. World J. Gastroenterol. 2012; 18: 800-805.
64. Schaalan MF, Mohamed WA, Amin HH. Vitamin D deficiency: correlation to interleukin-17, interleukin-23 and PIIINP in hepatitis C virus genotype 4. World J. Gastroenterol. 2012; 18: 3738-3744.
65. Gal-Tanamy M, Bachmetov L, Ravid A etal. Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes. Hepatology 2011; 54: 1570-1579.
66. Matsumura T, Kato T, Sugiyama N etal. 25-hydroxyvitamin D(3) suppresses hepatitis C virus production. Hepatology 2012; 56: 1231-1239.
67. Falleti E, Bitetto D, Fabris C etal. Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C. Hepatology 2012; 56: 1641-1650.
68. Tanaka A, Nezu S, Uegaki S etal. Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populations. J. Hepatol. 2009; 50: 1202-1209.
69. Fan L, Tu X, Zhu Y etal. Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese. J. Gastroenterol. Hepatol. 2005; 20: 249-255.
70. Baur K, Mertens JC, Schmitt J etal. Combined effect of 25-OH vitamin D plasma levels and genetic vitamin D receptor (NR 1I1) variants on fibrosis progression rate in HCV patients. Liver Int. 2012; 32: 635-643.